Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1
Yilong Ai, Shiwei Liu, Hailing Luo, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-15
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Role of m6A writers, erasers and readers in cancer
Zhen Fang, Wentong Mei, Chang Qu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 148
Current insight into the regulation of PD-L1 in cancer
Zhuandi Liu, Xibao Yu, Ling Xu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 63
Roles and therapeutic implications of m6A modification in cancer immunotherapy
Juan Pan, Tuxiong Huang, Zhenjun Deng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance
Dexin Xu, Wenhai Wang, Duo Wang, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 388-406
Open Access | Times Cited: 12
Small molecule inhibitors targeting m6A regulators
Guotai Feng, Yongya Wu, Yuan Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 12
LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer
Zhengwei Song, Xiaoguang Wang, Fei Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 34
Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy
Xianyong Zhou, Chen Li, Tong Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 22
Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination
Zhijia Sun, Haixing Mai, Chunyuan Xue, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 12, pp. e007415-e007415
Open Access | Times Cited: 19
The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing
Tongxuan Wen, Tong Li, Yeqiu Xu, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Targeting RNA N6-methyladenosine modification: a precise weapon in overcoming tumor immune escape
Wei Li, Yi Hao, Xingda Zhang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 28
Regulation of m6A modification on ferroptosis and its potential significance in radiosensitization
Xun Chen, Lejia Zhang, Yi He, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 15
Mechanism of METTL14 and m6A modification of lncRNA MALAT1 in the proliferation of oral squamous cell carcinoma cells
Jinli Li, Fatemeh Momen‐Heravi, Xun Wu, et al.
Oral Diseases (2022) Vol. 29, Iss. 5, pp. 2012-2026
Closed Access | Times Cited: 21
N6-methyladenosine (m6A) reader IGF2BP2 stabilizes HK2 stability to accelerate the Warburg effect of oral squamous cell carcinoma progression
Xu Ke, Xiaojuan Dai, Jiankun Wu, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 148, Iss. 12, pp. 3375-3384
Closed Access | Times Cited: 20
Roles of RNA Methylations in Cancer Progression, Autophagy, and Anticancer Drug Resistance
Hyein Jo, Kyeonghee Shim, Dooil Jeoung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4225-4225
Open Access | Times Cited: 11
Ferroptosis: a critical mechanism of N6-methyladenosine modification involved in carcinogenesis and tumor progression
Qingqing Wei, Changning Xue, Mengna Li, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 6, pp. 1119-1132
Closed Access | Times Cited: 4
METTL protein family: focusing on the occurrence, progression and treatment of cancer
Huhu Zhang, Fulin Sun, Shuyao Jiang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
The Role of M6A Modification in Autoimmunity: Emerging Mechanisms and Therapeutic Implications
Liyun Xu, Tian Shen, Yongzhen Li, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Closed Access
Analysis of mutually exclusive expression in cancer cells identifies a previously unknown intergenic regulatory paradigm
Ling Tang, Yuzhe Hu, Chao Wang, et al.
FEBS Journal (2025)
Closed Access
Orchestration of immunoregulatory signaling ligand and receptor dynamics by mRNA modifications: Implications for therapeutic potential
Zizhao Mai, Xu Chen, Ye Lu, et al.
International Journal of Biological Macromolecules (2025), pp. 142987-142987
Closed Access
The emerging significance of the METTL family as m6A-modified RNA methyltransferases in head and neck cancer
Ming Yang, Zile Zhang, Hao Qin, et al.
Cellular Signalling (2025), pp. 111798-111798
Closed Access
METTL3 promotes oral squamous cell carcinoma by regulating miR-146a-5p/SMAD4 axis
Jayasree Peroth Jayaprakash, Pragati Karemore, Piyush Khandelia
Oncotarget (2025) Vol. 16, Iss. 1, pp. 291-309
Open Access
The protein arginine methyltransferase family (PRMTs) regulates metastases in various tumors: From experimental study to clinical application
Jiaoyang Ning, Liu Chen, Gang Xiao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115456-115456
Open Access | Times Cited: 9
Cancer-associated fibroblasts secret extracellular vesicles to support cell proliferation and epithelial-mesenchymal transition in laryngeal squamous cell carcinoma
Tingting Li, Linli Tian, Jing Cao, et al.
Molecular and Cellular Probes (2023) Vol. 72, pp. 101934-101934
Open Access | Times Cited: 9
Verbascoside inhibits oral squamous cell carcinoma cell proliferation, migration, and invasion by the methyltransferase 3-mediated microRNA-31-5p/homeodomain interacting protein kinase 2 axis
Yuhua Huang, Wei Wu, Xing Zhang
Archives of Oral Biology (2024) Vol. 164, pp. 105979-105979
Closed Access | Times Cited: 3
Abnormal changes in metabolites caused by m6A methylation modification: The leading factors that induce the formation of immunosuppressive tumor microenvironment and their promising potential for clinical application
Liang Zhao, Junchen Guo, Shasha Xu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top